Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aprecia Appoints Regulatory Affairs SVP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Aprecia Appoints Regulatory Affairs SVP

Kathi Rinesmith to oversee strategic regulatory affairs for the company's expanding pipeline of 3D-printed pharmaceuticals.

By: Contract Pharma

Contract Pharma Staff

Aprecia, the 3DP Pharmaceutical Company, has appointed Kathi Rinesmith, R.Ph., MS as senior vice president of regulatory affairs. Rinesmith will lead the company’s regulatory strategy, objectives, policies and programs pertaining to the development and marketing of drug products manufactured with Aprecia’s proprietary three-dimensional printing (3DP) technology platform, ZipDose Technology.
 
Rinesmith brings more than thirty years of experience related to the development and registration of pharmaceutical products ranging from early and late-stage product development, product approvals, and life-cycle management across several therapeutic areas.
 
Prior to joining Aprecia, Rinesmith served as director of global regulatory affairs and global pharmacovigilance at the specialty CDMO company Adare Pharmaceuticals. Earlier in her career, Rinesmith held senior executive product development and regulatory roles at Camargo Pharmaceutical Services, Prasco Laboratories, Barr Labs and Duramed Pharmaceuticals.
 
“Kathi has comprehensive experience and qualifications that will be instrumental in advancing Aprecia’s pipeline and will be a resource for our partners to achieve regulatory and commercial success,” said Aprecia CEO, Chris Gilmore. “Her leadership and strategic vision will enhance the future of Aprecia.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters